Our 95%+ employee retention rate reflects our B Corp ethos, which puts people at the center of what we do. With 300+ Statisticians and Programmers across the globe, we take a people-focused approach to clinical analytics that has provided 100% on-time deliverables for all our clients with 0 FDA findings.
Why choose a specialist CRO like Veramed?
Katherine HutchinsonKatherine has 35 years of experience within the pharmaceutical industry, in large and small pharma, as well as 20+ years in the service sector. Her statistical career has spanned all phases of drug development through supporting regulatory submissions, post-submission registries and observational studies. In her managerial career, Katherine has gained an in-depth knowledge of operational and client account management, supporting and developing staff in their careers, whilst maintaining a focus on client needs.
Stuart McGuireStuart is responsible for leading the development of the business as it evolves its position as the pharmaceutical industry’s preferred statistics and programming CRO partner. Stuart has over 20 years of Pharmaceutical experience having first started work in anti-malaria research which took him to Moshi, Tanzania. He then moved to the Clinical Research Organisation Chiltern (latterly Covance) where he took on Business Development, Leadership and Alliance Partnership roles delivering significant growth over 19 years. Stuart has a wide platform of relationships in the pharmaceutical and biotech industry, covering Europe, North America and Japan.
Our 95%+ employee retention rate reflects our B Corp ethos, which puts people at the center of what we do. With 300+ Statisticians and Programmers across the globe, we take a people-focused approach to clinical analytics that has provided 100% on-time deliverables for all our clients with 0 FDA findings.
Why choose a specialist CRO like Veramed? Download now.
Katherine has 35 years of experience within the pharmaceutical industry, in large and small pharma, as well as 20+ years in the service sector. Her statistical career has spanned all phases of drug development through supporting regulatory submissions, post-submission registries and observational studies. In her managerial career, Katherine has gained an in-depth knowledge of operational and client account management, supporting and developing staff in their careers, whilst maintaining a focus on client needs.
Stuart is responsible for leading the development of the business as it evolves its position as the pharmaceutical industry’s preferred statistics and programming CRO partner. Stuart has over 20 years of Pharmaceutical experience having first started work in anti-malaria research which took him to Moshi, Tanzania. He then moved to the Clinical Research Organisation Chiltern (latterly Covance) where he took on Business Development, Leadership and Alliance Partnership roles delivering significant growth over 19 years. Stuart has a wide platform of relationships in the pharmaceutical and biotech industry, covering Europe, North America and Japan.
We are a Certified B Corporation®. B Corps™ are for-profit companies that use the power of business to build a more inclusive and sustainable economy. They meet the highest verified standards of social and environmental performance, transparency, and accountability. As of 2023, there are more than 6000 B Corps™ in 160 industries and 80 countries across the world. Check out the B Corp™ website for all certified B Corps™. Learn more about B Corps™, why we certified, the assessment process and our continuous dedication to improvement here.
Veramed is a pioneering CRO redefining intelligent healthcare decision-making through end-to-end biometrics. We bring together people, innovation, and technology together with world-class governance to accelerate evidence generation and advance patient health. With skilled statisticians and programmers uniquely matched and scaled to client needs, we produce exceptional deliverables swiftly using a blend of skill, rigorous governance, and automation to optimize the speed and success of clinical research from design through to submission and beyond.
